Abstract
Hepatocellular carcinoma (HCC) is the most common primary hepatic neoplasm. Thanks to recent advances in computed tomography (CT) and magnetic resonance imaging (MRI), there is potential to improve detection, segmentation, discrimination from HCC mimics, and monitoring of therapeutic response. Radiomics, artificial intelligence (AI), and derived tools have already been applied in other areas of diagnostic imaging with promising results. In this review, we briefly discuss the current clinical applications of radiomics and AI in the detection, segmentation, and management of HCC. Moreover, we investigate their potential to reach a more accurate diagnosis of HCC and to guide proper treatment planning.
Reference172 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018
2. World Health Organization (2017). Global Hepatitis Report 2017, World Health Organization.
3. Radiomics of hepatocellular carcinoma;Lewis;Abdom. Radiol.,2021
4. Radiomics: Images are more than pictures, they are data;Gillies;Radiology,2016
5. Russell, S., and Norvig, P. (2003). Artificial Intelligence: A Modern Approach, Prentice Hall Press.